Urgent notice: Delay selling and using question people immunoglobulin (Ig)

Urgent notice: Delay selling and using question people immunoglobulin (Ig)
Urgent notice: Delay selling and using question people immunoglobulin (Ig)
In order to guarantee the public uses the medicine security, SFDA and Ministry of Public Health release the urgent notice, demand to delay selling and using and labelling all lot number quiet note immunoglobulin (Ig) emergency measures of people produced for the learned bio-pharmaceuticals Co., Ltd. of Jiangxi immediately, and require enterprises to recall 20070514 lot number products rapidly. May 29, SFDA receives the report of monitoring center of bad reaction of national medicines, Jiangxi the intersection of Nanchang and the intersection of university and second affiliated hospital use, label lot number that Co., Ltd. produce 20070514 immunoglobulin (Ig) ( pH4), people of intravenous injection, for the intersection of Jiangxi and learned bio-pharmaceuticals It and then not appear incidents bads serious,it is the 22nd - 28 May, 6 persons successively, is the specifications for 5% (2.5g) in using by lot number patient that institute go to a doctor Intravenous injection choose the right person immunoglobulin (Ig) PH4 ( Liquid) And then die. At present, SFDA has already made up the investigation group and gone to Jiangxi for the relevant investigation. Hospital, the intersection of management and enterprise, sample of manufacturing enterprise that collect examine send off already, the preliminary test result reveals, some samples exist unusually. On May 29, the supervision departments at all levels seal all relevant products in the area under one's jurisdiction up for safekeeping immediately, Jiangxi Province office still investigated question medicines flowing into, use and stock situation that very night. According to should save the intersection of office and report, all the intersection of question and the intersection of lot number and medicines control already at present. By June 2, except second affiliated hospital in Nanchang university, there is not a bad reaction report which use the above-mentioned lot number medicines temporarily in the other provinces. (Wang Dan)


|